Objective. To assess the effectiveness original Indapamide (Arifon Retard, Servier, France) in patients with arterial hypertension and type 2 diabetes mellitus. Design and methods. 30 hypertensive subjects (mean age — 55 ± 4,0 years) with type 2 diabetes mellitus and uncontrolled hypertension, who took any of generic forms of Indapamide. Generic forms were substituted by original drug in all subjects (Arifon Retard). The follow-up lasted for 3 months. We assessed blood pressure changes, achievement of target blood pressure level, the changes of blood pressure according to 24-hout blood pressure monitoring. All subjects also filled in the questionnaires on life quality MOS SF-36 (MOS 36-ltem Short-Form Health Survey). Results. The mean decrease of blood pressure was 29/15 mm Hg. 80 % patients achieved target blood pressure levels. The therapy with original form of Indapamide was safe. We observed the decrease of plasma glucose level, of serum levels of total cholesterol, triglycerides, and low density lipoproteins, while there was a slight increase of the level of high density lipoproteins. According to the survey, the quality of life (MOS SF-36) the indicators of physical and mental health considerably increased. Results. Original Indapamide shows benefits in controlling blood pressure in high risk subjects, in particular, in hypertensive patients with type 2 diabetes mellitus.